What is OS Therapies's preferred stock, shares issued?

OS Therapies (OSTX) reported preferred stock, shares issued of $0 in Q1 2026.

What is the long-term trend for OS Therapies's preferred stock, shares issued?

Over 3 years (2021 to 2025), OS Therapies's preferred stock, shares issued has grown at a -100.0% compound annual growth rate (CAGR), from $1.3M to $0.

OS Therapies OSTX Preferred Stock, Shares Issued

Preferred Stock, Shares Issued at other companies

Apollo Global ManagementAPO

28.7M0.0%

eBayEBAY

0—

Mondelez InternationalMDLZ

0—

L3Harris TechnologiesLHX

0—

Wells Fargo & CompanyWFC

$4.55M-2.8%

MSCIMSCI

0—

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's preferred stock, shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's preferred stock, shares issued?: OS Therapies (OSTX) reported preferred stock, shares issued of $0 in Q1 2026.
What is the long-term trend for OS Therapies's preferred stock, shares issued?: Over 3 years (2021 to 2025), OS Therapies's preferred stock, shares issued has grown at a -100.0% compound annual growth rate (CAGR), from $1.3M to $0.